Lindsey Rolfe - Feb 14, 2024 Form 3 Insider Report for PHOENIX BIOTECH ACQUISITION CORP. (CERO)

Role
Director
Signature
/s/ Charles Carter, attorney-in-fact
Stock symbol
CERO
Transactions as of
Feb 14, 2024
Transactions value $
$0
Form type
3
Date filed
2/16/2024, 07:29 PM
Previous filing
Jun 15, 2023
Next filing
Mar 27, 2024

No securities are beneficially owned.

Remarks:

Exhibit 24 - Power of Attorney. Effective immediately after the Effective Time as defined in that certain Business Combination Agreement dated as of June 4, 2023, as amended, by and among the Issuer (f/k/a Phoenix Biotech Acquisition Corp.), CERo Therapeutics, Inc. and PBCE Merger Sub, Inc., the reporting person was elected as a member of the board of directors of the Issuer.